Arhalofenate: Phase IIb data

Top-line data from a double-blind, international Phase IIb trial in 239 patients with gout, hyperuricemia and a history of >=3 flares in the last 12 months showed that 800

Read the full 294 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE